rs749588235
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PM2PP3PP5
The NM_006567.5(FARS2):c.461C>T(p.Ala154Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,613,906 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A154A) has been classified as Likely benign.
Frequency
Consequence
NM_006567.5 missense
Scores
Clinical Significance
Conservation
Publications
- metabolic diseaseInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- combined oxidative phosphorylation defect type 14Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hereditary spastic paraplegia 77Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: MODERATE Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FARS2 | ENST00000274680.9 | c.461C>T | p.Ala154Val | missense_variant | Exon 2 of 7 | 1 | NM_006567.5 | ENSP00000274680.4 | ||
FARS2 | ENST00000324331.10 | c.461C>T | p.Ala154Val | missense_variant | Exon 2 of 7 | 1 | ENSP00000316335.5 | |||
FARS2 | ENST00000648580.1 | n.461C>T | non_coding_transcript_exon_variant | Exon 2 of 9 | ENSP00000497889.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152036Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251280 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461870Hom.: 0 Cov.: 32 AF XY: 0.0000371 AC XY: 27AN XY: 727244 show subpopulations
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152036Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74274 show subpopulations
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 77 Pathogenic:2
- -
- -
Combined oxidative phosphorylation defect type 14 Uncertain:2
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 154 of the FARS2 protein (p.Ala154Val). This variant is present in population databases (rs749588235, gnomAD 0.004%). This missense change has been observed in individual(s) with FARS2 deficiency (PMID: 29126765). ClinVar contains an entry for this variant (Variation ID: 488360). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt FARS2 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at